查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1904590

肠道健康和益生菌食品市场预测至2032年：按产品类型、益生菌菌株、剂型、分销管道、最终用户和地区分類的全球分析

Gut Health & Probiotic Foods Market Forecasts to 2032 - Global Analysis By Product Type, Probiotic Strain, Form, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计到 2025 年，全球肠道健康和益生菌食品市场价值将达到 803.9 亿美元，到 2032 年将达到 1,308 亿美元，在预测期内的复合年增长率为 7.2%。

肠道健康和益生菌食品是一种旨在透过维持肠道微生物的健康平衡来改善消化器官系统的膳食补充剂。这些产品富含活性有益菌、膳食纤维和功能性成分，能够滋养肠道生态系。持续食用有助于改善消化、增强免疫反应、有效吸收营养并预防胃肠道不适。透过支持微生物多样性和肠道健康，这些食品在促进长期健康和预防消化系统疾病方面发挥重要作用。

消化系统疾病呈上升趋势

消费者越来越意识到肠道菌丛在整体健康中的作用，这推动了富含益生菌的机能性食品的普及。诊断工具的进步正在识别更多消化失衡的人群，进一步扩大了消费群。人口老化和久坐的生活方式也导致全球消化系统併发症率的上升。医学专家建议将富含益生菌的饮食作为预防和治疗措施。人们对整体健康和自然疗法的日益关注，进一步凸显了肠道健康解决方案的重要性。因此，益生菌食品正逐渐成为主流，既作为膳食补充剂，也作为日常消费品。

研发和生产高成本

为了确保产品质量，製造商必须投资先进的发酵技术和可控的生产环境。此外，由于益生菌食品必须符合多个地区的严格安全和标籤标准，因此合规性也会带来额外的成本。小规模公司往往由于缺乏专业设备和技术而难以参与竞争。高昂的生产成本导致产品定价偏高，这可能会限制价格敏感型消费者的购买力。如何在扩大生产规模的同时保持活性菌群的存活率，仍然是一项技术挑战。

个人化营养与人工智慧

人工智慧驱动的平台能够根据个人的微生物组特征提供个人化的饮食建议。消费者越来越倾向于寻求能够解决特定消化器官系统问题和实现特定健康目标的客製化解决方案。数据分析技术和穿戴式健康设备的进步使得将益生菌融入个人化饮食计划成为可能。企业正在利用机器学习来预测消费者偏好并优化产品开发。这种技术与营养的融合正在推动消费者参与度和忠诚度的提升。随着个人化成为现代健康理念的标誌，益生菌食品有望从中受益匪浅。

与製药解决方案的竞争

与饮食疗法相比，处方药通常能更快缓解症状。针对微生物组的药物开发平臺不断扩展，对益生菌食品的广泛普及构成了直接挑战。消费者可能认为，如果药物有实验室检测支持或由医生推荐，则更值得信赖。医疗保险对医疗程序的涵盖进一步增强了药物相对于食品类替代品的优势。益生菌生产商必须透过强调预防保健和长期益处来使产品脱颖而出。

新冠疫情的影响

疫情改变了消费者的关注重点，免疫力和肠道健康比以往任何时候都更加受到重视。封锁导致的供应链中断使得多个地区的益生菌产品供不应求。然而，健康意识的提高也带动了对增强抵抗力和促进健康的机能性食品的需求。在出行限制期间，线上零售通路对于维持产品供应至关重要。製造商加快了数位化行销宣传活动，以教育消费者了解肠道健康与免疫力之间的关联。监管机构也推出了临时性的弹性措施，以确保消费者能够持续获得必需的益生菌补充剂。疫情后，益生菌食品公司的策略重点是增强市场韧性、拓展电子商务以及实现采购多元化。

预计在预测期内，乳酸菌细分市场将占据最大的市场份额。

由于乳酸菌在乳製品、饮料和膳食补充剂等领域的广泛应用，预计在预测期内，乳酸菌细分市场将占据最大的市场份额。大量文献证实，乳酸菌菌株能够改善消化功能并增强免疫功能。其稳定性以及与各种食品基质的相容性使其用途广泛。消费者透过优格等传统产品熟悉乳酸菌，增强了消费者对其的信任和接受度。持续的研究不断证实乳酸菌在治疗胃肠道疾病和促进整体健康方面的有效性。製造商正在投资开发胶囊、粉末和强化零食等创新产品形式。

预计在预测期内，线上零售/电子商务领域的复合年增长率将最高。

预计在预测期内，线上零售/电子商务领域将保持最高的成长率。电子商务平台为消费者提供了便利的管道，让他们能够购买到种类繁多的益生菌产品。数位化管道支援个人化推荐和订阅模式，从而提高了客户维繫。疫情加速了消费者向网路购物的转变，并带来了持久的行为改变。企业正利用社群媒体和网红行销来提升品牌知名度和信誉度。提供透明化服务和客製化产品组合的直接面向消费者（D2C）品牌正在崛起。随着数位生态系统的扩展，线上零售预计仍将是益生菌食品领域最具活力的驱动力。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额。中国、印度和日本等国家拥有悠久的发酵食品传统，有助于益生菌在当地文化中被广泛接受。可支配收入的成长和都市化正在推动该地区对机能性食品的需求。各国政府正大力进行健康宣传宣传活动，并专注于营养和预防性医疗保健。当地製造商正在扩大产能以满足不断增长的国内需求。与全球企业的策略合作正在加速技术转移和创新。

复合年均成长率最高的地区

预计中东和非洲地区在预测期内将实现最高的复合年增长率。人们对文明病的日益关注推动了功能性营养的发展。西式饮食习惯在都市区日益盛行，进而催生了益生菌强化产品的需求。本地产能有限导致进口增加，国际品牌也随之渗透。各国政府增加对医疗基础设施和健康促进措施的投资，间接促进了益生菌的广泛应用。线上零售平台的快速扩张，提高了服务不足市场的可近性。

免费客製化服务讯息

购买此报告的客户可享有以下免费自订选项之一：

  • 公司概况
    • 最多三家新增市场参与企业进行全面分析
    • 主要企业SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户要求，对主要国家进行市场估算和预测，并计算复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 从产品系列、地域覆盖范围和策略联盟等方面对主要参与企业进行基准分析

目录

第一章执行摘要

第二章 前言

  • 摘要
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球肠道健康与益生菌食品市场（依产品类型划分）

  • 乳製品益生菌食品
  • 非乳製品/植物来源益生菌食品
  • 发酵食品
  • 机能饮料
  • 肠道健康补充剂
  • 其他的

6. 全球肠道环境与益生菌食品市场（依益生菌菌株划分）

  • 乳酸菌
  • 双歧桿菌
  • 布氏酵母
  • 其他的

7. 全球肠道环境与益生菌食品市场（按类型划分）

  • 液体
  • 粉末
  • 胶囊和片剂
  • 食品添加物

8. 全球肠道健康与益生菌食品市场（依分销管道划分）

  • 超级市场/大卖场
  • 药房和药品商店
  • 健康食品和特色商店
  • 直接面向消费者的品牌
  • 线上零售/电子商务

9. 全球肠道健康和益生菌食品市场（按最终用户划分）

  • 成人
  • 儿童
  • 老年人
  • 临床和医疗应用
  • 其他的

第十章 全球肠道健康与益生菌食品市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：企业概况

  • Nestle SA
  • Valio Ltd.
  • Danone SA
  • Probi AB
  • Yakult Honsha Co., Ltd.
  • Sanofi SA
  • Chr. Hansen Holding A/S
  • Amway Corporation
  • DuPont
  • Kerry Group plc
  • PepsiCo, Inc.
  • BioGaia AB
  • General Mills, Inc.
  • Lallemand Inc.
  • Arla Foods amba
Product Code: SMRC33130

According to Stratistics MRC, the Global Gut Health & Probiotic Foods Market is accounted for $80.39 billion in 2025 and is expected to reach $130.80 billion by 2032 growing at a CAGR of 7.2% during the forecast period. Gut Health & Probiotic Foods are nutrition-based products designed to enhance digestive system functionality by maintaining a healthy balance of intestinal microbes. They are enriched with live beneficial bacteria, supportive fibers, and functional ingredients that nourish the gut ecosystem. Consistent intake aids in better digestion, improved immune response, efficient nutrient uptake, and protection against gastrointestinal imbalances. By supporting microbial diversity and gut integrity, these foods play a vital role in promoting long-term health and preventing digestive-related ailments.

Market Dynamics:

Driver:

Increasing prevalence of GI disorders

Consumers are increasingly aware of the role gut microbiota plays in overall health, driving adoption of functional foods enriched with probiotics. As diagnostic tools improve, more individuals are being identified with digestive imbalances, further expanding the consumer base. Aging populations and sedentary lifestyles are also contributing to higher rates of GI complications worldwide. Probiotic-rich diets are being promoted by healthcare professionals as preventive and therapeutic measures. The growing emphasis on holistic wellness and natural remedies is reinforcing the importance of gut health solutions. Consequently, probiotic foods are becoming mainstream as both dietary supplements and everyday consumables.

Restraint:

High Costs of R&D and production

Manufacturers must invest in advanced fermentation technologies and controlled environments to maintain product quality. Regulatory compliance adds further expense, as probiotic foods must meet stringent safety and labeling standards across multiple regions. Smaller firms often struggle to compete due to limited access to specialized equipment and expertise. High production costs can lead to premium pricing, restricting accessibility for price-sensitive consumers. Scaling up production while maintaining live culture viability remains a technical challenge.

Opportunity:

Personalized nutrition & AI

AI-driven platforms are enabling tailored dietary recommendations based on individual microbiome profiles. Consumers are increasingly seeking customized solutions that address specific digestive issues or wellness goals. Advances in data analytics and wearable health devices are supporting the integration of probiotics into personalized diet plans. Companies are leveraging machine learning to predict consumer preferences and optimize product development. This convergence of technology and nutrition is fostering greater consumer engagement and loyalty. As personalization becomes a hallmark of modern wellness, probiotic foods are positioned to benefit significantly.

Threat:

Competition from pharmaceutical solutions

Prescription medications often provide faster symptom relief compared to dietary interventions. The growing pipeline of microbiome-targeted drugs poses a direct challenge to probiotic food adoption. Consumers may perceive pharmaceuticals as more reliable due to clinical trial backing and physician endorsements. Insurance coverage for medical treatments further tilts the balance against food-based alternatives. Probiotic manufacturers must differentiate their offerings by emphasizing preventive health and long-term benefits.

Covid-19 Impact:

The pandemic reshaped consumer priorities, with immunity and gut health gaining unprecedented attention. Lockdowns disrupted supply chains, leading to shortages of probiotic products in several regions. However, heightened health awareness boosted demand for functional foods that support resilience and recovery. Online retail channels became critical in maintaining product availability during restricted physical movement. Manufacturers accelerated digital marketing campaigns to educate consumers about the link between gut health and immunity. Regulatory agencies introduced temporary flexibilities to ensure continued access to essential probiotic supplements. Post-pandemic strategies now emphasize resilience, e-commerce expansion, and diversified sourcing for probiotic food companies.

The lactobacillus segment is expected to be the largest during the forecast period

The lactobacillus segment is expected to account for the largest market share during the forecast period, due to its widespread application in dairy, beverages, and supplements. Lactobacillus strains are well-documented for improving digestion and enhancing immune function. Their stability and compatibility with multiple food matrices make them highly versatile. Consumers are familiar with lactobacillus through traditional products like yogurt, which reinforces trust and adoption. Ongoing research continues to validate their efficacy in managing GI disorders and promoting overall wellness. Manufacturers are investing in innovative delivery formats such as capsules, powders, and fortified snacks.

The online retail/E-commerce segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the online retail/E-commerce segment is predicted to witness the highest growth rate. E-commerce platforms provide consumers with convenient access to a wide range of probiotic products. Digital channels enable personalized recommendations and subscription models, enhancing customer retention. The pandemic accelerated the shift toward online shopping, creating lasting behavioral changes. Companies are leveraging social media and influencer marketing to boost visibility and trust. Direct-to-consumer brands are thriving by offering transparency and tailored product bundles. As digital ecosystems expand, online retail will remain the most dynamic growth driver for probiotic foods.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share. Countries like China, India, and Japan have strong traditions of fermented foods, supporting cultural acceptance of probiotics. Rising disposable incomes and urbanization are increasing demand for functional foods in the region. Governments are promoting health awareness campaigns that emphasize nutrition and preventive care. Local manufacturers are expanding production capacity to meet growing domestic demand. Strategic partnerships with global players are accelerating technology transfer and innovation.

Region with highest CAGR:

Over the forecast period, the Middle East & Africa region is anticipated to exhibit the highest CAGR. Rising awareness of lifestyle-related diseases is driving interest in functional nutrition. Urban populations are increasingly adopting Western dietary habits, creating demand for probiotic-enriched products. Limited local production capacity is encouraging imports and international brand penetration. Governments are investing in healthcare infrastructure and wellness initiatives, indirectly supporting probiotic adoption. Online retail platforms are expanding rapidly, improving accessibility in underserved markets.

Key players in the market

Some of the key players in Gut Health & Probiotic Foods Market include Nestle S.A., Valio Ltd., Danone S.A., Probi AB, Yakult Honsha Co., Ltd., Sanofi S.A., Chr. Hansen Holding A/S, Amway Corporation, DuPont de Nemours, Inc., Kerry Group plc, PepsiCo, Inc., BioGaia AB, General Mills, Inc., Lallemand Inc., and Arla Foods.

Key Developments:

In September 2025, DuPont has signed an agreement to acquire Sinochem (Ningbo) RO Memtech Co., Ltd. to expand its reverse osmosis (RO) manufacturing footprint into China and the Asia Pacific region. With advanced membrane and fabrication production technologies, the acquisition increases DuPont's capacity to meet the growing demand in the region for FilmTec(TM) elements for industrial water purification and reuse.

In September 2025, Danone announced the inauguration of its OneBiome Laboratory in Paris-Saclay, marking a major milestone in its commitment to science-based innovation and leadership in gut health research. The Danone OneBiome Lab will serve as a global hub for microbiome science, nutrition, and digital health, reinforcing Danone's pioneering role in shaping the future of food and health.

Product Types Covered:

  • Dairy-based Probiotic Foods
  • Non-dairy/Plant-based Probiotic Foods
  • Fermented Foods
  • Functional Beverages
  • Gut Health Supplements
  • Other Product Types

Probiotic Strains Covered:

  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces boulardii
  • Other Emerging Strains

Forms Covered:

  • Liquid
  • Powder
  • Capsule/Tablets
  • Food Additives

Distribution Channels Covered:

  • Supermarkets/Hypermarkets
  • Pharmacies & Drug Stores
  • Health & Specialty Stores
  • Direct-to-Consumer Brands
  • Online Retail/E-commerce

End Users Covered:

  • Adults
  • Children
  • Elderly Population
  • Clinical/Medical Use
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut Health & Probiotic Foods Market, By Product Type

  • 5.1 Introduction
  • 5.2 Dairy-based Probiotic Foods
  • 5.3 Non-dairy/Plant-based Probiotic Foods
  • 5.4 Fermented Foods
  • 5.5 Functional Beverages
  • 5.6 Gut Health Supplements
  • 5.7 Other Product Types

6 Global Gut Health & Probiotic Foods Market, By Probiotic Strain

  • 6.1 Introduction
  • 6.2 Lactobacillus
  • 6.3 Bifidobacterium
  • 6.4 Saccharomyces boulardii
  • 6.5 Other Emerging Strains

7 Global Gut Health & Probiotic Foods Market, By Form

  • 7.1 Introduction
  • 7.2 Liquid
  • 7.3 Powder
  • 7.4 Capsule/Tablets
  • 7.5 Food Additives

8 Global Gut Health & Probiotic Foods Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Supermarkets/Hypermarkets
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Health & Specialty Stores
  • 8.5 Direct-to-Consumer Brands
  • 8.6 Online Retail/E-commerce

9 Global Gut Health & Probiotic Foods Market, By End User

  • 9.1 Introduction
  • 9.2 Adults
  • 9.3 Children
  • 9.4 Elderly Population
  • 9.5 Clinical/Medical Use
  • 9.6 Other End Users

10 Global Gut Health & Probiotic Foods Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Nestle S.A.
  • 12.2 Valio Ltd.
  • 12.3 Danone S.A.
  • 12.4 Probi AB
  • 12.5 Yakult Honsha Co., Ltd.
  • 12.6 Sanofi S.A.
  • 12.7 Chr. Hansen Holding A/S
  • 12.8 Amway Corporation
  • 12.9 DuPont
  • 12.10 Kerry Group plc
  • 12.11 PepsiCo, Inc.
  • 12.12 BioGaia AB
  • 12.13 General Mills, Inc.
  • 12.14 Lallemand Inc.
  • 12.15 Arla Foods amba

List of Tables

  • Table 1 Global Gut Health & Probiotic Foods Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut Health & Probiotic Foods Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Gut Health & Probiotic Foods Market Outlook, By Dairy-based Probiotic Foods (2024-2032) ($MN)
  • Table 4 Global Gut Health & Probiotic Foods Market Outlook, By Non-dairy/Plant-based Probiotic Foods (2024-2032) ($MN)
  • Table 5 Global Gut Health & Probiotic Foods Market Outlook, By Fermented Foods (2024-2032) ($MN)
  • Table 6 Global Gut Health & Probiotic Foods Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 7 Global Gut Health & Probiotic Foods Market Outlook, By Gut Health Supplements (2024-2032) ($MN)
  • Table 8 Global Gut Health & Probiotic Foods Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Gut Health & Probiotic Foods Market Outlook, By Probiotic Strain (2024-2032) ($MN)
  • Table 10 Global Gut Health & Probiotic Foods Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 11 Global Gut Health & Probiotic Foods Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 12 Global Gut Health & Probiotic Foods Market Outlook, By Saccharomyces boulardii (2024-2032) ($MN)
  • Table 13 Global Gut Health & Probiotic Foods Market Outlook, By Other Emerging Strains (2024-2032) ($MN)
  • Table 14 Global Gut Health & Probiotic Foods Market Outlook, By Form (2024-2032) ($MN)
  • Table 15 Global Gut Health & Probiotic Foods Market Outlook, By Liquid (2024-2032) ($MN)
  • Table 16 Global Gut Health & Probiotic Foods Market Outlook, By Powder (2024-2032) ($MN)
  • Table 17 Global Gut Health & Probiotic Foods Market Outlook, By Capsule/Tablets (2024-2032) ($MN)
  • Table 18 Global Gut Health & Probiotic Foods Market Outlook, By Food Additives (2024-2032) ($MN)
  • Table 19 Global Gut Health & Probiotic Foods Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 20 Global Gut Health & Probiotic Foods Market Outlook, By Supermarkets/Hypermarkets (2024-2032) ($MN)
  • Table 21 Global Gut Health & Probiotic Foods Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 22 Global Gut Health & Probiotic Foods Market Outlook, By Health & Specialty Stores (2024-2032) ($MN)
  • Table 23 Global Gut Health & Probiotic Foods Market Outlook, By Direct-to-Consumer Brands (2024-2032) ($MN)
  • Table 24 Global Gut Health & Probiotic Foods Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 25 Global Gut Health & Probiotic Foods Market Outlook, By End User (2024-2032) ($MN)
  • Table 26 Global Gut Health & Probiotic Foods Market Outlook, By Adults (2024-2032) ($MN)
  • Table 27 Global Gut Health & Probiotic Foods Market Outlook, By Children (2024-2032) ($MN)
  • Table 28 Global Gut Health & Probiotic Foods Market Outlook, By Elderly Population (2024-2032) ($MN)
  • Table 29 Global Gut Health & Probiotic Foods Market Outlook, By Clinical/Medical Use (2024-2032) ($MN)
  • Table 30 Global Gut Health & Probiotic Foods Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.